Study Links Ultra-Processed Foods to Declined Focus and Elevated Dementia Risk

Recent research reveals that consuming a diet rich in ultra-processed foods (UPFs) may subtly impair cognitive function, even for those who generally maintain a nutritious diet.

An analysis involving over 2,100 Australians, who were middle-aged and older and free from dementia, indicated that high intake of extensively processed foods can detrimentally affect the brain’s concentration abilities and heighten the risk of dementia.

Conducted by Monash University, the study demonstrated that even slight upticks in UPF consumption were associated with reduced attention spans.

Dr. Barbara Cardoso, the study’s lead researcher, highlighted that these effects were not only consistent but also quantifiable.

“With each 10 percent rise in ultra-processed food intake, there was a clear and quantifiable decrease in an individual’s focus,” she explained.

She said a 10 per cent increase in UPFs is roughly equivalent to adding a standard packet of chips to your daily diet.

In clinical terms, this translated into lower scores on standardised tests, with a decrease in focus and slower thinking.

What counts as ultra-processed food?

Ultra-processed foods include widely consumed items such as soft drinks, packaged salty snacks and ready-made meals — products that are far removed from their original wholefood form.

Participants in the study consumed an average of 41 per cent of their daily energy from these foods, closely aligning with Australia’s national average of 42 per cent.

“The more ultra processed foods they consumed, the worse their capacity was to focus or concentrate,” Cardoso told SBS News.

“The data suggests that these foods can be detrimental to cognitive health, starting from the young adulthood stage of life.”

Healthy diets not a safeguard

One of the study’s most significant findings was that that UPFs had negative effects regardless of overall diet quality.

Even individuals following otherwise healthy dietary patterns, including Mediterranean-style diets, experienced declines in attention when they increased their intake of UPFs.

This suggests that how food is processed may matter just as much as what nutrients it contains.

“The adherence to a Mediterranean-style diet did not counterbalance the negative association we found for ultra-processed foods,” Cardoso said.

She noted that ultra-processing of food often destroys its natural structure, introducing potentially harmful substances like artificial additives or processing chemicals.

‘They end up transforming the food matrix to remove some important components of the food and also adding some other ingredients that we don’t normally have in our pantry like emulsifiers [and] colourants, which seem to have detrimental health effects.”

A warning sign for long-term brain health

While the study did not find a direct link between ultra-processed foods and memory loss, researchers emphasised that attention is a foundational cognitive function.

It underpins critical processes such as learning, decision-making and problem-solving, meaning even subtle declines could have broader implications over time.

Higher consumption of UPFs was also associated with increased dementia risk factors, including conditions like high blood pressure and obesity, which are managed to help protect brain health.

“We know that ultra-processed foods are associated with cardiovascular disease and Type 2 diabetes, which are conditions tightly associated with dementia risk,” Cardoso said.

A growing area of concern

The findings add to a growing body of evidence suggesting that industrial food processing itself, not just poor nutrition, may play a role in cognitive decline.

With ultra-processed foods making up a significant portion of the average Australian diet, researchers say the results highlight the importance of looking beyond traditional definitions of “healthy eating”.

One form of dementia closely linked to lifestyle factors is vascular dementia, caused by damage to blood vessels in the brain.

While there is currently no treatment, researchers at UNSW Sydney have just mapped out new potential genetic targets aimed at developing future therapies.

Dr Matthew Lennon from the University of NSW told SBS News that this research looks at what medications could be repurposed, and what new molecules could be invented to try to target these genes.

He added a large proportion of the risk is linked to lifestyle and genetics, including things like high blood pressure, diabetes, cholesterol and obesity.

The Monash University study draws on data from the Healthy Brain Project and was supported by organisations including the National Health and Medical Research Council, and the Alzheimer’s Association.

For the latest from SBS News, download our app and subscribe to our newsletter.